Open Strategies for Innovation in the Public Sector: Challenges and Opportunities

La col·laboració amb socis externs proporciona un mitjà per ampliar la base de coneixement d'una empresa, reduir els temps de desenvolupament del producte, augmentar la innovació i proporcionar avantatges competitius. Aquesta tesi contribueix a la recerca en innovació oberta i de l'usuari mitjançant l'exploració qualitativa d’estratègies en el context del sector públic. La tesi pretén comprendre els motors subjacents de la innovació cívica a partir dels esforços innovadors de ciutats europees i americanes. Les ciutats accedeixen a la informació tàcita de l'usuari aprofitant el context i la tecnologia per proporcionar solucions innovadores col·laborant amb plataformes i organitzacions cíviques. Es proposa un enfocament integral de l'ecosistema, ampliant les conceptualitzacions actuals dels ecosistemes empresarials. L'èmfasi en la capacitat desorptive en les organitzacions cíviques es considera una elusió del bloqueig, a causa dels dèficits cívics en capacitat d'absorció. La importància dels processos d'innovació situats en entorns del món real s'examina en líving labs, mentre es compara amb altres metodologies. A més a més, aquesta tesis proposa en el context de la Open Public Policy Innovation una eina millorada per tal d’accedir a la informació tàcita dels usuaris.La colaboración con socios externos proporciona un medio para ampliar la base de conocimiento de una empresa, reducir los tiempos de desarrollo del producto, aumentar la innovación y proporcionar ventajas competitivas. Esta tesis contribuye a la investigación en innovación abierta y del usuario mediante la exploración cualitativa de estrategias en el contexto del sector público. La tesis pretende comprender los motores subyacentes de la innovación cívica a partir de los esfuerzos innovadores de ciudades europeas y americanas. Las ciudades acceden a la información tácita del usuario aprovechando el contexto y la tecnología para proporcionar soluciones innovadoras colaborando con plataformas y organizaciones cívicas. Se propone un enfoque integral del ecosistema, ampliando las conceptualizaciones actuales de los ecosistemas empresariales. El énfasis en la capacidad desorptive en las organizaciones cívicas se considera una elusión del bloqueo, debido a los déficits cívicos en capacidad de absorción. La importancia de los procesos de innovación situados en entornos del mundo real se examina en living labs, mientras se compara con otras metodologías. Además, esta tesis propone en el contexto de la Open Public Policy Innovation una herramienta mejorada para acceder a la información tácita de los usuarios.Collaboration with external partners provides a means of expanding a firm’s knowledge base, decreasing product development timelines, increasing innovation, and providing competitive advantage. This thesis contributes to the research in open innovation and user innovation by exploring these strategies in the context of the public sector. By examining nascent innovation endeavors in European and American cities, the thesis seeks to understand the underlying drivers of civic innovation, how civic organizations foster communities of collaborators and civic platforms, and how governments access tacit user information by leveraging context and technology to provide innovative solutions. An Integrated Ecosystem Approach is proposed, expanding current conceptualizations of business ecosystems. An emphasis on desorptive capacity in civic organizations is considered as a circumvention of lockout, due to civic deficits in absorptive capacity. The importance of innovation processes situated in real-world environments is examined in living labs, as compared to other methodologies. And an enhanced utility of technology as a tool for accessing tacit user information is proposed in the context of Open Public Policy Innovation

Consensus-Based Evaluation of Outcome Measures in Pediatric Stroke Care: A Toolkit

Following a pediatric stroke, outcome measures selected for monitoring functional recovery and development vary widely. We sought to develop a toolkit of outcome measures that are currently available to clinicians, possess strong psychometric properties, and are feasible for use within clinical settings. A multidisciplinary group of clinicians and scientists from the International Pediatric Stroke Organization comprehensively reviewed the quality of measures in multiple domains described in pediatric stroke populations including global performance, motor and cognitive function, language, quality of life, and behavior and adaptive functioning. The quality of each measure was evaluated using guidelines focused on responsiveness and sensitivity, reliability, validity, feasibility, and predictive utility. A total of 48 outcome measures were included and were rated by experts based on the available evidence within the literature supporting the strengths of their psychometric properties and practical use. Only three measures were found to be validated for use in pediatric stroke: the Pediatric Stroke Outcome Measure, the Pediatric Stroke Recurrence and Recovery Questionnaire, and the Pediatric Stroke Quality of Life Measure. However, multiple additional measures were deemed to have good psychometric properties and acceptable utility for assessing pediatric stroke outcomes. Strengths and weaknesses of commonly used measures including feasibility are highlighted to guide evidence-based and practicable outcome measure selection. Improving the coherence of outcome assessment will facilitate comparison of studies and enhance research and clinical care in children with stroke. Further work is urgently needed to close the gap and validate measures across all clinically significant domains in the pediatric stroke population

Improved quality control processing of peptide-centric LC-MS proteomics data

Motivation: In the analysis of differential peptide peak intensities (i.e. abundance measures), LC-MS analyses with poor quality peptide abundance data can bias downstream statistical analyses and hence the biological interpretation for an otherwise high-quality dataset. Although considerable effort has been placed on assuring the quality of the peptide identification with respect to spectral processing, to date quality assessment of the subsequent peptide abundance data matrix has been limited to a subjective visual inspection of run-by-run correlation or individual peptide components. Identifying statistical outliers is a critical step in the processing of proteomics data as many of the downstream statistical analyses [e.g. analysis of variance (ANOVA)] rely upon accurate estimates of sample variance, and their results are influenced by extreme values

Interlaboratory comparison study of the Colony Forming Efficiency assay for assessing cytotoxicity of nanomaterials

Nanotechnology has gained importance in the past years as it provides opportunities for industrial growth and innovation. However, the increasing use of manufactured nanomaterials (NMs) in a number of commercial applications and consumer products raises also safety concerns and questions regarding potential unintended risks to humans and the environment. Since several years the European Commission’s Joint Research Centre (JRC) is putting effort in the development, optimisation and harmonisation of in vitro test methods suitable for screening and hazard assessment of NMs. Work is done in collaboration with international partners, in particular the Organisation for Economic Co-operation and Development (OECD). This report presents the results from an interlaboratory comparison study of the in vitro Colony Forming Efficiency (CFE) cytotoxicity assay performed in the frame of OECD's Working Party of Manufactured Nanomaterials (WPMN). Twelve laboratories from European Commission, France, Italy, Japan, Poland, Republic of Korea, South Africa and Switzerland participated in the study coordinated by JRC. The results show that the CFE assay is a suitable and robust in vitro method to assess cytotoxicity of NMs. The assay protocol is well defined and is easily and reliably transferable to other laboratories. The results obtained show good intra and interlaboratory reproducibility of the assay for both the positive control and the tested nanomaterials. In conclusion the CFE assay can be recommended as a building block of an in vitro testing battery for NMs toxicity assessment. It could be used as a first choice method to define dose-effect relationships for other in vitro assays.JRC.I.4-Nanobioscience

The Fourteenth Data Release of the Sloan Digital Sky Survey: First Spectroscopic Data from the extended Baryon Oscillation Spectroscopic Survey and from the second phase of the Apache Point Observatory Galactic Evolution Experiment

The fourth generation of the Sloan Digital Sky Survey (SDSS-IV) has been in operation since July 2014. This paper describes the second data release from this phase, and the fourteenth from SDSS overall (making this, Data Release Fourteen or DR14). This release makes public data taken by SDSS-IV in its first two years of operation (July 2014-2016). Like all previous SDSS releases, DR14 is cumulative, including the most recent reductions and calibrations of all data taken by SDSS since the first phase began operations in 2000. New in DR14 is the first public release of data from the extended Baryon Oscillation Spectroscopic Survey (eBOSS); the first data from the second phase of the Apache Point Observatory (APO) Galactic Evolution Experiment (APOGEE-2), including stellar parameter estimates from an innovative data driven machine learning algorithm known as "The Cannon"; and almost twice as many data cubes from the Mapping Nearby Galaxies at APO (MaNGA) survey as were in the previous release (N = 2812 in total). This paper describes the location and format of the publicly available data from SDSS-IV surveys. We provide references to the important technical papers describing how these data have been taken (both targeting and observation details) and processed for scientific use. The SDSS website (www.sdss.org) has been updated for this release, and provides links to data downloads, as well as tutorials and examples of data use. SDSS-IV is planning to continue to collect astronomical data until 2020, and will be followed by SDSS-V.Comment: SDSS-IV collaboration alphabetical author data release paper. DR14 happened on 31st July 2017. 19 pages, 5 figures. Accepted by ApJS on 28th Nov 2017 (this is the "post-print" and "post-proofs" version; minor corrections only from v1, and most of errors found in proofs corrected

The degree of segmental aneuploidy measured by total copy number abnormalities predicts survival and recurrence in superficial gastroesophageal adenocarcinoma

Background: Prognostic biomarkers are needed for superficial gastroesophageal adenocarcinoma (EAC) to predict clinical outcomes and select therapy. Although recurrent mutations have been characterized in EAC, little is known about their clinical and prognostic significance. Aneuploidy is predictive of clinical outcome in many malignancies but has not been evaluated in superficial EAC. Methods: We quantified copy number changes in 41 superficial EAC using Affymetrix SNP 6.0 arrays. We identified recurrent chromosomal gains and losses and calculated the total copy number abnormality (CNA) count for each tumor as a measure of aneuploidy. We correlated CNA count with overall survival and time to first recurrence in univariate and multivariate analyses. Results: Recurrent segmental gains and losses involved multiple genes, including: HER2, EGFR, MET, CDK6, KRAS (recurrent gains); and FHIT, WWOX, CDKN2A/B, SMAD4, RUNX1 (recurrent losses). There was a 40-fold variation in CNA count across all cases. Tumors with the lowest and highest quartile CNA count had significantly better overall survival (p = 0.032) and time to first recurrence (p = 0.010) compared to those with intermediate CNA counts. These associations persisted when controlling for other prognostic variables. Significance: SNP arrays facilitate the assessment of recurrent chromosomal gain and loss and allow high resolution, quantitative assessment of segmental aneuploidy (total CNA count). The non-monotonic association of segmental aneuploidy with survival has been described in other tumors. The degree of aneuploidy is a promising prognostic biomarker in a potentially curable form of EAC. © 2014 Davison et al

The Bulge Metallicity Distribution from the APOGEE Survey

The Apache Point Observatory Galactic Evolution Experiment (APOGEE) provides spectroscopic information of regions of the inner Milky Way, which are inaccessible to optical surveys. We present the first large study of the metallicity distribution of the innermost Galactic regions based on high-quality measurements for 7545 red giant stars within 4.5 kpc of the Galactic center, with the goal to shed light on the structure and origin of the Galactic bulge. Stellar metallicities are found, through multiple Gaussian decompositions, to be distributed in several components, which is indicative of the presence of various stellar populations such as the bar or the thin and the thick disks. Super-solar ([Fe/H] = +0.32) and solar ([Fe/H] = +0.00) metallicity components, tentatively associated with the thin disk and the Galactic bar, respectively, seem to be major contributors near the midplane. A solar-metallicity component extends outwards in the midplane but is not observed in the innermost regions. The central regions (within 3 kpc of the Galactic center) reveal, on the other hand, the presence of a significant metal-poor population ([Fe/H] = −0.46), tentatively associated with the thick disk, which becomes the dominant component far from the midplane ($| Z| \geqslant +0.75$ kpc). Varying contributions from these different components produce a transition region at +0.5 kpc $\leqslant \,| Z| \,\leqslant \ +1.0\,\mathrm{kpc}$, characterized by a significant vertical metallicity gradient